Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer

NCT05462613 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

446

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

OTHER: quality of life questionnaires
PROCEDURE: Blood sample
DRUG: Regorafenib
DRUG: Metronomic chemotherapies
DRUG: Aspirin
DRUG: Bevacizumab
DRUG: FOLFIRI or FOLFOX

Sponsor

Centre Hospitalier Universitaire de Besancon